The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Vyant Bio Inc(NASDAQ:VYNT) 
Vyant Bio operates two wholly-owned subsidiaries, StemoniX and vivoPharm. The Company will immediately begin to execute on the integration of these two leading businesses, to converge human-powered scientific and technology-based systems and expertise with years of preclinical experience to de-risk ...
Website: https://www.vyantbio.com/
Founded: 1999
CEO: Jay Roberts
Sector: Health Care and Social Assistance
Industry: Medical Laboratories
Share this website to your friends
Vyant Bio Days Payable Outstanding ttm (DPO)
Vyant Bio Days Receivable Outstanding ttm (DSO)
Vyant Bio Days Inventory Outstanding ttm (DIO)
Vyant Bio Op Cashflow Per Share ttm
Vyant Bio Free Cashflow Per Share ttm
Vyant Bio Cash Per Share ttm
Vyant Bio P/S ratio ttm
Vyant Bio (GAAP) P/E ratio ttm
Vyant Bio P/B ratio ttm
No extra charts and metrics for this ticker.